In conclusion, we have demonstrated in this study the strong anti-tumor activity of BCA both in vitro and in vivo by increasing intracellular ROS and mitochondrial division and inhibiting aerobic glycolysis in glioma cells. The gene discussed is BLNK; the disease is glioma.